Navigation Links
Linagliptin Demonstrated Significant HbA1c Reduction in Elderly People With Type 2 Diabetes With Inadequate Glycemic Control
Date:8/15/2013

ely controlled diabetes, and adds to the growing body of evidence for the safety and efficacy profile for linagliptin in this population."

About the study

The study was conducted at 33 centers in five countries (Australia, Canada, Denmark, The Netherlands and Sweden). A total of 241 people who were (>/=70 years with T2D, had HbA1c of (>/=7.0 percent and received metformin and/or sulfonylurea and/or basal insulin were randomized 2:1 to once-daily oral treatment with linagliptin 5 mg or placebo for 24 weeks.

What are TRADJENTA tablets?

TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

TRADJENTA is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

If you have had inflammation of the pancreas (pancreatitis) in the past, it is not known if you have a higher chance of getting pancreatitis while you take TRADJENTA.

Important Safety Information

What is the most important information I should know about TRADJENTA?
Serious side effects can happen to people taking TRADJENTA, including inflammation of the pancreas (pancreatitis), which may be severe and lead to death. Before you start taking TRADJENTA, tell your doctor if you have ever had pancreatitis, gallstones, a history of alcoholism, or high triglyceride levels.

Stop taking TRADJENTA and call your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

Who should not take TRADJENTA?
Do not take TRADJENTA if you are allergic to linagliptin or any of the ingr
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
2. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
3. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
4. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
7. Haemonetics Reports 1st Quarter Fiscal 2014 Revenue Up 24%; Adjusted EPS of $0.46 Up 46%; Adjusted Operating Margin Improvement of 270 Basis Points; and Significant Progress on Planned Manufacturing Transformation
8. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
9. Groundbreaking UK Study Confirms Significant Reduction in Hospital Superbug Pathogens with TRU-D SmartUVC Disinfection Robot
10. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
11. Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Md. , Aug. 28, 2014 ... of novel anti-infective biologic and drug candidates targeting ... and FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced ... phase of cGMP manufacturing of SYN-004, Synthetic Biologics, ... Clostridium difficile ( C. difficile ) ...
(Date:8/28/2014)... 28, 2014 Today is the official launch ... higher education, student and pharmaceutical organizations that will work ... ADHD prescription stimulant medication. The Coalition will initially focus ... reported rates of nonmedical use vary, a 2013 study ... 1 of college students reported nonmedical use of ...
(Date:8/27/2014)... 27, 2014 TWi Pharmaceuticals, Inc. (4180.TT) today ... the United States Food and Drug Administration (FDA) ... megestrol acetate 125mg/ml oral suspension, the generic equivalent ... first-to-file and under Hatch Waxman rules, it will ...  TWi has completed the pre-launch preparation of the ...
Breaking Medicine Technology:Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2
... -- American Oriental Bioengineering, Inc. (NYSE: AOB ) ... (the "NYSE") has notified the Company that it is not ... to timely file its Annual Report on Form 10-K with ... rules, when a Company does not comply with annual report ...
...  In conjunction with its first quarter 2012 earnings release (expected to be ... CVD ) is pleased to invite you to listen to its ... on Thursday, May 3, 2012 at 9:00 a.m. ET. , ... and Slide Presentation , , , , When: , , , ...
Cached Medicine Technology:American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard 2
(Date:8/28/2014)... 28, 2014 Vitals, a recognized and trusted ... Fabi of Cosmetic Laser Dermatology one of their Top ... of patients to share their doctor experiences and rate their ... time, and follow-ups. The Vitals Top 10 Doctor recognition means ... was ranked one of the highest by patients. , “I’m ...
(Date:8/28/2014)... 2014 Altec Products, Inc., a ... announced today that they have been awarded the ... of the International Association of Microsoft Channel Partners ... founded in 1994, providing Microsoft Partners with a ... community at large while facilitating mutual growth and ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 The Baltimore ... web design firms in Baltimore and awarded The ... on 2013 revenue from Web design, The Canton Group ... The Canton Group’s clients include Fortune 1000, higher education, ... organizations. The Canton Group specializes in web design and ...
(Date:8/28/2014)... 28, 2014 Postcard-worthy views, star-laden skies, ... glamping by the beach in your own private bungalow ... Palmar at the Islands of Loreto. , The newest ... unforgettable experience in paradise with its romantic Honeymoon package, ... 2014. , “Villa del Palmar at the Islands of ...
(Date:8/28/2014)... Labor Day weekend typically conjures up images ... glorious glimpses of summer. However, more of Dr. ... their long weekend recovering from a quick cosmetic procedure. ... plastic and reconstructive surgeon based out of Newport Beach, ... their holiday weekends to do something for themselves. ...
Breaking Medicine News(10 mins):Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:The Canton Group is Recognized by the Baltimore Business Journal as the Largest Web Design Firm in Baltimore 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 2Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 3Health News:Honeymoon in Paradise at Villa del Palmar at the Islands of Loreto 4Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 2Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 3Health News:Newport Beach Facial Plastic Surgeon, Dr. Kevin Sadati Announces a Patient Trend of Scheduling Cosmetic Surgery Procedures over Long Holiday Weekends 4
... New research challenges the previously held belief that infants' ... new study finds the brain's left hemisphere plays the ... immediately after birth. ,Researchers are using functional ... activity in response to speech. They say this is ...
... try to avoid getting it, but researchers say common cold ... genetically engineer the common cold virus so that //it kills ... They did this by modifying one gene, so the virus ... the activity of another gene to ensure that the virus ...
... Government guidelines on the treatment of asthma have long ... for people with persistent forms of the condition.But reports ... people -- including parents of asthmatic children -- to ... growth retardation in children, weak bones in children and ...
... therapeutic option for patients with complicated type 1 diabetes, ... // Now, a new study finds ... worse survival than patients on the transplant waiting list ... Association supports a pancreatic transplant for patients who have ...
... a vaccine made from the common cold virus may induce ... the Centers for Disease Control and Prevention injected six monkeys ... parts of the SARS coronavirus. A new form of the ... were given a second vaccine 28 days later, and researchers ...
... women with diabetes have a higher risk of depression., ... 60 and 79. The participants were divided //into two ... the second included those without diabetes. Women who did ... groups, based on their levels of insulin resistance. ...
Cached Medicine News:Health News:New Technique to Study Infants Brain. 2Health News:Benefits and Risks of Asthma Treatment Questioned 2Health News:Pancreas Transplant for Diabetics 2
... GV is a sterile, non-pyrogenic, transparent ... noninflammatory, high molecular weight (average = ... hyaluronate. Healon GV contains 14 mg/mL ... a physiological sodium chloride-phosphate buffer (pH ...
... PROVISC ophthalmic viscosurgical device ... is characterized by high molecular ... surface tension. It provides excellent ... and is easily removed. It ...
... a product comes along that forever raises ... category. The new StealthStation TREON plus Treatment ... Built on the phenomenal success of the ... system in the worldthe new TREON plus ...
... the DigiCat Imager ("DCI") to provide rapid, ... The DCI can measure the cataract and ... objective, appropriate and timely surgical decision can ... technology is especially useful in todays healthcare ...
Medicine Products: